Evaluation of the Preventive Effect of Chlorhexidine Acetate Gargle for Upper Gastrointestinal Tract Infection After ESD
NCT03492827 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 306
Last updated 2018-04-10
Summary
Backgrounds: With the continuous improvement of sterilization and endoscopic structure, the infection caused by endoscopy has gradually declined.With the rapid development of digestive endoscopic therapy in the past decade, therapeutic endoscopy has been widely carried out worldwide. These techniques have caused the mucous membrane or deeper damage to achieve the goal of curing the disease. During therapeutic endoscopic procedures, endogenous bacteria may be ectopic to the blood circulation due to mucosal or deeper damage. The endoscope is used to in and out lumens multiple times, and the injections are injected into the tissues through the accessories. These processes may bring the pathogenic bacteria from the patient's mouth into the digestive tract through the endoscope and enter the blood through the damaged mucosa. In addition, bacteremia associated with endoscopic procedures may cause bacterial infections in distant organs (eg infective endocarditis).
Postoperative infection rates can reach 12-22% . The results of the etiological culture show that it is consistent with the bacteria of oral bacteria. It is possibly related to multiple passage into the digestive tract of endoscopic and accessory . However, the endoscopic operation process will inevitably lead to subsequent infections.
ESD treatment involves endoscopic multiple access to the upper digestive tract through the mouth, attachments and injection needles and other multiple exposure to the wound, so the probability of postoperative infection is significantly higher than the average endoscope.
Investigators proposed to gargle patients with chlorhexidine acetate before ESD to improve the oral microenvironment and reduce the pathogenic bacteria in the oral cavity, so as to observe whether it can achieve the effect of preventing postoperative infection.
Methods and patients
1. Objectives: This study is a prospective randomized controlled study in single center of Peking University Third Hospital. The purpose of the study is to evaluate the preventive effect of chlorhexidine acetate gargle on the infection of early upper gastrointestinal cancer after endoscopic ESD therapy.
2. Calculation of sample size: According to the postoperative infection rate of 10%, 25% improvement is given after the gargle is administered, and the error range is calculated at 2%. The sample size needs 306 cases.
Conditions
- Esophageal Cancer
- Gastric Cancer
Interventions
- DRUG
-
chlorhexidine acetate gargle
observe whether it can achieve the effect of preventing postoperative infection
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Principal Investigators
-
Yonghui Huang, MD · Peking University Third Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- SEQUENTIAL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-01
- Primary Completion
- 2019-06-30
- Completion
- 2019-09-30
Countries
- China
Study Locations
More Related Trials
-
The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding
NCT02695732 ·Status: UNKNOWN ·Phase: PHASE4
-
The Impact of Comprehensive Education Before Gastroscopy on Improving the Tolerance of Patients
NCT03638752 ·Status: COMPLETED ·Phase: NA
-
Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy
NCT05455372 ·Status: UNKNOWN ·Phase: NA
-
Esophagogastroduodenoscopy (EGD) is an Aerosol-generating Procedure: Proof of Concept Study
NCT04400734 ·Status: UNKNOWN
-
Application of Simethicone in Esophagogastroscopy
NCT03776916 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal Bleeding
NCT06437964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Carbon-13 (13C)-Spirulina Platensis Gastric Emptying Breath Test (GEBT)
NCT01248221 ·Status: COMPLETED ·Phase: NA
-
The Application of Extracellular Vesicle Detection in Gastric Juice Based on Metamaterial Sensing in the Diagnosis of Gastric Cancer and Related Diseases
NCT07332104 ·Status: NOT_YET_RECRUITING
-
Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists
NCT04984382 ·Status: UNKNOWN ·Phase: NA
-
Methane and Hydrogen Breath Test for the Diagnosis of Small Intestinal Bacterial Overgrowth
NCT06483360 ·Status: NOT_YET_RECRUITING
-
Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
NCT02112214 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer
NCT00596401 ·Status: COMPLETED
-
Intestinal Adsorbent and Breath Gas Levels
NCT04492839 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects
NCT01677338 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study
NCT03142620 ·Status: UNKNOWN ·Phase: PHASE3
-
Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer
NCT04989153 ·Status: UNKNOWN
-
Effect of Simethicone on Helicobacter Pylori Detection in Routine Endoscopy
NCT07293234 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia
NCT00764374 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer
NCT01002443 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy
NCT05790525 ·Status: COMPLETED ·Phase: PHASE4
-
Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia
NCT04449185 ·Status: UNKNOWN ·Phase: PHASE4
-
Surveillance of Bleeding Peptic Ulcer Using Wireless Capsule Endoscopy
NCT00164827 ·Status: UNKNOWN
-
The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding
NCT07261228 ·Status: RECRUITING
-
Small Volume Simethicone Before Gastroscopy: Any Benefit?
NCT02555228 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD
NCT02407119 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3